A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Ulcerative Colitis
Interventions
DRUG

CP- 690 550

Administration via oral route twice daily for the duration of treatment

DRUG

CP- 690 550

Administration via oral route twice daily for the duration of treatment

DRUG

CP- 690 550

Administration via oral route twice daily for the duration of treatment

DRUG

CP- 690 550

Administration via oral route twice daily for the duration of treatment

OTHER

placebo

Administration via oral route twice daily for the duration of treatment

Trial Locations (59)

1125

Pfizer Investigational Site, Budapest

1135

Pfizer Investigational Site, Budapest

2020

Pfizer Investigational Site, Antwerp

2193

Pfizer Investigational Site, Johannesburg

3000

Pfizer Investigational Site, Leuven

3529

Pfizer Investigational Site, Miskolc

4001

Pfizer Investigational Site, Durban

4004

Pfizer Investigational Site, Debrecen

4091

Pfizer Investigational Site, Overport

5600

Pfizer Investigational Site, Békéscsaba

5701

Pfizer Investigational Site, Gyula

6600

Pfizer Investigational Site, Szentes

6720

Pfizer Investigational Site, Szeged

7100

Pfizer Investigational Site, Szekszárd

7400

Pfizer Investigational Site, Kaposvár

7550

Pfizer Investigational Site, Durbanville

7708

Pfizer Investigational Site, Claremont

8000

Pfizer Investigational Site, Aarhus C

9000

Pfizer Investigational Site, Ghent

9023

Pfizer Investigational Site, Győr

9100

Pfizer Investigational Site, Aalborg

9200

Pfizer Investigational Site, Mosonmagyaróvár

13915

Pfizer Investigational Site, Marseille

14000

Pfizer Investigational Site, Tlalpan

28222

Pfizer Investigational Site, Majadahonda

31096

Pfizer Investigational Site, Haifa

33075

Pfizer Investigational Site, Bordeaux

40138

Pfizer Investigational Site, Bologna

44093

Pfizer Investigational Site, Nantes

49100

Pfizer Investigational Site, Petah Tikva

50012

Pfizer Investigational Site, Hradec Králové

59037

Pfizer Investigational Site, Lille

64239

Pfizer Investigational Site, Tel Aviv

94901

Pfizer Investigational Site, Nitra

2570017

Pfizer Investigational Site, Viña del Mar

8380418

Pfizer Investigational Site, Independencia

8380456

Pfizer Investigational Site, Independencia

90610-000

Pfizer Investigational Site, Porto Alegre

01244-030

Pfizer Investigational Site, São Paulo

05651-901

Pfizer Investigational Site, São Paulo

775 20

Pfizer Investigational Site, Olomouc

401 13

Pfizer Investigational Site, Usti N. Labem

Pfizer Investigational Site, Ústí nad Labem

00152

Pfizer Investigational Site, Roma

03300

Pfizer Investigational Site, Delegacion Benito Juarez

1081 HV

Pfizer Investigational Site, Amsterdam

85-168

Pfizer Investigational Site, Bydgoszcz

90-153

Pfizer Investigational Site, Lodz

50-556

Pfizer Investigational Site, Wroclaw

826 06

Pfizer Investigational Site, Bratislava

811 07

Pfizer Investigational Site, Bratislava

08036

Pfizer Investigational Site, Barcelona

08907

Pfizer Investigational Site, L'Hospitalet de Llobregat

901 85

Pfizer Investigational Site, Umeå

351 85

Pfizer Investigational Site, Vaxjo

BS2 8HW

Pfizer Investigational Site, Bristol

G11 6NT

Pfizer Investigational Site, Glasgow

G4 0SS

Pfizer Investigational Site, Glasgow

M13 9WL

Pfizer Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY